| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors M Berk, F Kapczinski, AC Andreazza, OM Dean, F Giorlando, M Maes, ... Neuroscience & biobehavioral reviews 35 (3), 804-817, 2011 | 1170 | 2011 |
| Studies on [3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use B Dean, S Sundram, R Bradbury, E Scarr, D Copolov Neuroscience 103 (1), 9-15, 2001 | 495 | 2001 |
| Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia XM Gao, K Sakai, RC Roberts, RR Conley, B Dean, CA Tamminga American Journal of Psychiatry, 2000 | 475 | 2000 |
| Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between … A Knafo, S Israel, A Darvasi, R Bachner‐Melman, F Uzefovsky, L Cohen, ... Genes, brain and behavior 7 (3), 266-275, 2008 | 382 | 2008 |
| Towards a muscarinic hypothesis of schizophrenia TJ Raedler, FP Bymaster, R Tandon, D Copolov, B Dean Molecular psychiatry 12 (3), 232-246, 2007 | 317 | 2007 |
| Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation JM Crook, E Tomaskovic-Crook, DL Copolov, B Dean Biological psychiatry 48 (5), 381-388, 2000 | 257 | 2000 |
| Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology A Fornito, M Yücel, B Dean, SJ Wood, C Pantelis Schizophrenia bulletin 35 (5), 973-993, 2009 | 255 | 2009 |
| Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann’s areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment JM Crook, E Tomaskovic-Crook, DL Copolov, B Dean American Journal of Psychiatry, 2001 | 237 | 2001 |
| Molecular profiles of schizophrenia in the CNS at different stages of illness S Narayan, B Tang, SR Head, TJ Gilmartin, JG Sutcliffe, B Dean, ... Brain research 1239, 235-248, 2008 | 212 | 2008 |
| Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia B Dean, M McLeod, D Keriakous, J McKenzie, E Scarr Molecular psychiatry 7 (10), 1083-1091, 2002 | 205 | 2002 |
| Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine LC Harrison, PG Colman, B Dean, R Baxter, FIR Martin Diabetes 34 (12), 1306-1308, 1985 | 183 | 1985 |
| Changes in Serotonin2A and GABAA Receptors in Schizophrenia: Studies on the Human Dorsolateral Prefrontal Cortex B Dean, T Hussain, W Hayes, E Scarr, S Kitsoulis, C Hill, K Opeskin, ... Journal of neurochemistry 72 (4), 1593-1599, 1999 | 180 | 1999 |
| A role for estrogen in schizophrenia: clinical and preclinical findings A Gogos, AM Sbisa, J Sun, A Gibbons, M Udawela, B Dean International journal of endocrinology 2015, 2015 | 174 | 2015 |
| Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder RE McCullumsmith, LV Kristiansen, M Beneyto, E Scarr, B Dean, ... Brain research 1127, 108-118, 2007 | 172 | 2007 |
| Autophagy has a key role in the pathophysiology of schizophrenia A Merenlender-Wagner, A Malishkevich, Z Shemer, M Udawela, ... Molecular psychiatry 20 (1), 126-132, 2015 | 165 | 2015 |
| The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. B Dean, JM Crook, K Opeskin, C Hill, N Keks, DL Copolov Molecular psychiatry 1 (1), 54-58, 1996 | 164 | 1996 |
| Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia A Torkamani, B Dean, NJ Schork, EA Thomas Genome research 20 (4), 403-412, 2010 | 155 | 2010 |
| Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation N Nakatani, E Hattori, T Ohnishi, B Dean, Y Iwayama, I Matsumoto, T Kato, ... Human molecular genetics 15 (12), 1949-1962, 2006 | 147 | 2006 |
| Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders EA Thomas, B Dean, G Pavey, JG Sutcliffe Proceedings of the National Academy of Sciences 98 (7), 4066-4071, 2001 | 147 | 2001 |
| Phospholipase C-β1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration CE McOmish, E Burrows, M Howard, E Scarr, D Kim, HS Shin, B Dean, ... Molecular psychiatry 13 (7), 661-672, 2008 | 145 | 2008 |
Andrew GibbonsMonash UniversityVerified email at monash.edu
